{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:31:40Z","timestamp":1649028700895},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fondo de Investigaciones Sanitarias","award":["PI09\/0624"],"award-info":[{"award-number":["PI09\/0624"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AFTDOC 11\/02"],"award-info":[{"award-number":["AFTDOC 11\/02"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004892","name":"Agencia Espa\u00f1ola de Cooperaci\u00f3n Internacional para el Desarrollo","doi-asserted-by":"publisher","award":["0000557290"],"award-info":[{"award-number":["0000557290"]}],"id":[{"id":"10.13039\/501100004892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.eimc.2015.11.008","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T20:02:26Z","timestamp":1453406546000},"page":"571-576","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Galactomannan enzyme immunoassay and quantitative Real Time PCR as tools to evaluate the exposure and response in a rat model of aspergillosis after posaconazole prophylaxis"],"prefix":"10.1016","volume":"34","author":[{"given":"Emilio","family":"Cendejas-Bueno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agustina","family":"Forastiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Mellado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Buitrago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Gavald\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Gomez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2015.11.008_bib0160","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/jac\/dks266","article-title":"Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation","volume":"67","author":"Herbrecht","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.11.008_bib0165","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4014\/jmb.1401.01067","article-title":"Evaluation of galactomannan enzyme immunoassay and quantitative real-time PCR for the diagnosis of invasive pulmonary aspergillosis in a rat model","volume":"24","author":"Lin","year":"2014","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.eimc.2015.11.008_bib0170","first-page":"172","article-title":"Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi","volume":"28","author":"Ruiz-Camps","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2015.11.008_bib0175","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2165\/11596540-000000000-00000","article-title":"Triazole antifungal agents in invasive fungal infections: a comparative review","volume":"71","author":"Lass-Florl","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.eimc.2015.11.008_bib0180","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ajh.10234","article-title":"Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation","volume":"71","author":"Koh","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.eimc.2015.11.008_bib0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00705-08","article-title":"Antifungal therapeutic drug monitoring: established and emerging indications","volume":"53","author":"Andes","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 6","key":"10.1016\/j.eimc.2015.11.008_bib0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12464","article-title":"The role of primary antifungal prophylaxis in patients with haematological malignancies","volume":"20","author":"Pagano","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.11.008_bib0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2015.11.008_bib0200","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1128\/AAC.00939-09","article-title":"Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adults","volume":"53","author":"Lebeaux","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.11.008_bib0205","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4065\/mcp.2011.0247","article-title":"Current concepts in antifungal pharmacology","volume":"86","author":"Lewis","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.eimc.2015.11.008_bib0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.00969-06","article-title":"Posaconazole prophylaxis in experimental systemic zygomycosis","volume":"51","author":"Barchiesi","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.11.008_bib0215","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1128\/AAC.00606-10","article-title":"Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis","volume":"54","author":"Mavridou","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.11.008_bib0220","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/AAC.45.3.857-869.2001","article-title":"Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia","volume":"45","author":"Petraitiene","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.11.008_bib0225","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/AAC.01463-09","article-title":"Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice","volume":"54","author":"Rodr\u00edguez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.11.008_bib0230","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/AAC.01445-09","article-title":"Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani","volume":"54","author":"Wiederhold","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.11.008_bib0235","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1469-0691.2008.02086.x","article-title":"EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds","volume":"14","author":"Rodriquez-Tudela","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.11.008_bib0240","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/mmy\/myt022","article-title":"An invertebrate model to evaluate virulence in Aspergillus fumigatus: the role of azole resistance","volume":"52","author":"Gomez-Lopez","year":"2014","journal-title":"Med Mycol"},{"key":"10.1016\/j.eimc.2015.11.008_bib0245","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1469-0691.2005.01262.x","article-title":"Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis","volume":"11","author":"Gavald\u00e0","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.11.008_bib0250","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1128\/AAC.00931-09","article-title":"Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene","volume":"54","author":"Mavridou","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.11.008_bib0255","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1469-0691.2011.03732.x","article-title":"HPLC\/UV or bioassay: two valid methods for posaconazole quantification in human serum samples","volume":"18","author":"Cendejas-Bueno","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.11.008_bib0260","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.eimc.2015.11.008_bib0265","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1128\/JCM.00328-14","article-title":"Performance of panfungal \u2013 and specific-PCR-based procedures for etiological diagnosis of invasive fungal diseases on tissue biopsy specimens with proven infection: a 7-year retrospective analysis from a reference laboratory","volume":"52","author":"Buitrago","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2015.11.008_bib0270","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/JCM.01716-08","article-title":"Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive Aspergillosis in patients with febrile neutropenia","volume":"47","author":"Cuenca-Estrella","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2015.11.008_bib0275","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/myc.12060","article-title":"Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy","volume":"56","author":"Hoenigl","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.eimc.2015.11.008_bib0280","first-page":"1","article-title":"The prevalence of antifungal agents administration in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective study","volume":"7","author":"Kargar","year":"2013","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"10.1016\/j.eimc.2015.11.008_bib0285","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/infdis\/jir023","article-title":"Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapy","volume":"203","author":"Howard","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2015.11.008_bib0290","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1128\/AAC.01279-12","article-title":"Posaconazole pharmacodynamic target determination against wild-type and Cyp51 mutant isolates of Aspergillus fumigatus in an in vivo model of invasive pulmonary aspergillosis","volume":"57","author":"Lepak","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.11.008_bib0295","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMe068266","article-title":"Prophylaxis and aspergillosis \u2013 has the principle been proven?","volume":"356","author":"De Pauw","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2015.11.008_bib0300","doi-asserted-by":"crossref","first-page":"e874","DOI":"10.1016\/j.ijid.2011.09.011","article-title":"Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance","volume":"15","author":"Racil","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.eimc.2015.11.008_bib0305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jcp.2011.090464","article-title":"Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis","volume":"65","author":"McCulloch","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.eimc.2015.11.008_bib0310","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1128\/AAC.00276-08","article-title":"Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture","volume":"52","author":"Vallor","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15004449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15004449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T02:25:06Z","timestamp":1537064706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X15004449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0213005X15004449"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2015.11.008","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galactomannan enzyme immunoassay and quantitative Real Time PCR as tools to evaluate the exposure and response in a rat model of aspergillosis after posaconazole prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2015.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}